BSE filing, NSE: BACPHAR. Summary written from the filing by ALFA Finder's alert engine.
Bacil Pharma Ltd: key numbers
- Share price
- ₹19.36
- Market cap
- ₹27.79 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹1.56 Cr
- P/E (TTM)
- 44.0×Sector 46.1×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bacil Pharma Ltd
All →Bacil Pharma Other Announcement
Bacil Pharma Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31.
Bacil Pharma Q2 FY27 Results: Net Loss of ₹0.1 Cr
Bacil Pharma Ltd reported a net loss of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.1 Cr
Bacil Pharma Management Change
Mr. Dikshant Singh Panwar has resigned as Whole-Time Company Secretary and Compliance Officer of Bacil Pharma Limited, effective October 8, 2026.
Bacil Pharma Board Meeting Date
Bacil Pharma will hold a board meeting on October 14, 2026, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026.
Bacil Pharma Annual General Meeting
Bacil Pharma Limited has announced book closure dates from September 17 to September 23, 2026, for its 39th Annual General Meeting.
Bacil Pharma Board Meeting Date
Bacil Pharma Limited has scheduled a board meeting for August 29, 2026, to discuss and approve the notice and scheduling of its 39th Annual General Meeting.
Other annual report announcements
All →LWS Knitwear Annual Report
LWS Knitwear files its FY 2025-26 Annual Report, including the 37th AGM notice set for 20 November 2026. No single material transaction is announced.
Punjab Communications Annual Report
Punjab Communications filed its 45th Annual Report for FY 2025-26 with BSE under SEBI LODR Reg 34(1). The report includes audited financials, board report, and 45th AGM notice.
Aban Offshore Annual Report
Aban Offshore filed its Annual Report for FY 2025-26, including the 40th AGM notice for 16 November 2026. The company remains under CIRP with powers suspended.
Vipul Annual Report
Vipul Limited submitted its 2025-26 Annual Report and the notice for its 35th Annual General Meeting, scheduled for November 12, 2026.
Supreme Infrastructure India Annual Report
Supreme Infrastructure India Limited filed its Annual Report for FY 2025-26 with the BSE. The report covers corporate overview, statutory reports, and financial statements.
Krishna Filament Industries Annual Report
Krishna Filament Industries has submitted its 38th Annual Report for the financial year 2025-26 along with the Notice of the Annual General Meeting.